Genomic Applications Partnership Program (GAPP)
The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects driven by challenges and opportunities identified by Receptor organizations.
The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects driven by challenges and opportunities identified by Receptor organizations.
Wildlife genome information is extremely valuable for environmental decision making, yet much remains unused for this purpose. This project draws together partners with expertise across disciplines, cultures and organizations, building upon team strengths in Arctic observation and monitoring, biology, conservation, cyber-cartography, data management, genomics, geography, Indigenous Knowledge, the legal and policy sciences, and resource management. …
In response to stakeholder consultations across the province, recommendations from post-secondary institutions, and support from the broader research and end-user community, Genome Alberta developed BioNet Alberta for Genome Canada’s Regional Priorities Partnership Program (RP3). BioNet Alberta is a diverse network-based approach to building provincial capacity in the area of bioinformatics and computational biology (B/CB). The …
More than 100 autoimmune diseases have complex immune responses to autoantigens. Nanoparticles coated with autoimmune-disease-relevant peptide-major histocompatibility complexes (Navacims) have the potential to halt and cure autoimmune disease by restoring immune tolerance without compromising normal immunity to infections and cancer. They are currently the only technology that can activate internal generation of disease-specific regulatory T …
Currently, non-urgent patients may routinely wait 1-2 years to see a metabolic geneticist, an additional 3-4 months to get approval for next generation sequencing (NGS), and an additional 4-6 months to obtain results and counseling. The project aims to establish a Canadian Prairie Metabolic Network (CPMN) and describes a unique, combined clinical and laboratory approach …
Disease is an economically important trait in Canadian pork production and is one of the most difficult challenges to manage. It also contributes to poor public perception of food animal production in terms of animal welfare, food safety, and antimicrobial resistance. Pig breeding companies (Users) represented by PigGen Canada are the foundation of the Canadian …
Application of genomics-based tools to select for pig disease resilience Read More »
Alberta patients with or suspected of having rare genetic diseases continue to face lengthy diagnostic odysseys, and clinical genome wide sequencing has emerged as a rapid and cost-effective approach to diagnosis. Large scale clinical genomics are not available in Alberta, and Alberta Precision Laboratories (APL) has relied primarily on US commercial labs to provide clinical …
TIGeR: Translational implementation of genomics for rare diseases Read More »
The federal contaminated sites inventory lists over 1000 soil and groundwater sites contaminated with BTEX compounds (Benzene, Toluene, Ethylbenzene, and Xylenes). BTEX present significant risks to human and environmental health, especially benzene, a known carcinogen. Benzene is also particularly challenging to remediate due to its slow biodegradation in the absence of oxygen. Genomics-based modeling of …
Field validation of technologies for anaerobic benzene and alkylbenzene bioremediation Read More »
Given the competitiveness among the super-majors to find and develop new oil and gas reservoirs around the world, and the billion-dollar cost of exploration programs, any proven enhancements in offshore exploration success will have an immediate economic return. This project focuses on de-risking exploration and development in offshore Nova Scotia by the validation and integration …